Hans Schambye
Impact in
- Immunology top 5%
- Galectins and Cancer Biology
- Toxin Mechanisms and Immunotoxins
-
- Neuropeptides and Animal Physiology
Papers in
-
- Receptor Mechanisms and Signaling 9
- Immunology 15
- Galectins and Cancer Biology 15
- Macrophage Migration Inhibitory Factor 5
- Co-authors
- Siv A. Hjorth (8 shared papers)Thue W. Schwartz (8 shared papers)William J. Greenlee (3 shared papers)Ulrik Gether (3 shared papers)Hakon Leffler (12 shared papers)Ulf J. Nilsson (9 shared papers)Alison C. MacKinnon (11 shared papers)Derk J. Bergsma (2 shared papers)
- Journals
- Peritoneal Dialysis International (4 papers)Journal of Biological Chemistry (3 papers)Journal of Medicinal Chemistry (2 papers)Gastroenterology (2 papers)Molecular Pharmacology (2 papers)
- Partner nations
- DenmarkSwedenUnited Kingdom
In The Last Decade
Hans Schambye
35 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 123
- Immunology 469
- Cellular and Molecular Neuroscience 339
- Nephrology 114
- Molecular Biology 967
- Gastroenterology 59
Countries citing papers authored by Hans Schambye
This map shows the geographic impact of Hans Schambye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Schambye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Schambye more than expected).
Fields of papers citing papers by Hans Schambye
This network shows the impact of papers produced by Hans Schambye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Schambye. The network helps show where Hans Schambye may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Schambye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 151 | |
| 2 | 1994 | 150 | |
| 3 | 1994 | 110 | |
| 4 | 2019 | 104 | |
| 5 | 2000 | 99 | |
| 6 | 2003 | 94 | |
| 7 | 1995 | 84 | |
| 8 | 1995 | 79 | |
| 9 | 2019 | 73 | |
| 10 | 2008 | 72 | |
| 11 | 1997 | 62 | |
| 12 | 2022 | 62 | |
| 13 | 2016 | 60 | |
| 14 | 1994 | 59 | |
| 15 | 1992 | 39 | |
| 16 | 1995 | 29 | |
| 17 | 1993 | 27 | |
| 18 | Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents. | 1992 | 27 |
| 19 | 1996 | 26 | |
| 20 | 2023 | 25 |
About Hans Schambye
Hans Schambye is a scholar working on Molecular Biology, Immunology, Oncology, Nephrology and Cardiology and Cardiovascular Medicine, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (15 papers), Receptor Mechanisms and Signaling (9 papers), Peptidase Inhibition and Analysis (6 papers), Renin-Angiotensin System Studies (5 papers), Dialysis and Renal Disease Management (5 papers), Macrophage Migration Inhibitory Factor (5 papers), Gastrointestinal motility and disorders (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Immunology (469 citations), Cellular and Molecular Neuroscience (339 citations), Nephrology (114 citations), Molecular Biology (967 citations) and Gastroenterology (59 citations). Hans Schambye has collaborated with scholars based in Denmark, Sweden and United Kingdom. Frequent co-authors include Siv A. Hjorth, Thue W. Schwartz, William J. Greenlee, Ulrik Gether, Hakon Leffler, Ulf J. Nilsson, Alison C. MacKinnon, Derk J. Bergsma, Ganesh M. Sathe and Tariq Sethi. Their work appears in journals such as Peritoneal Dialysis International, Journal of Biological Chemistry, Journal of Medicinal Chemistry, Gastroenterology and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.